- Home
- PCVX vs SNX Comparison
PCVX vs SNX Comparison
Compare PCVX & SNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCVX | SNX |
|---|---|---|
| Founded | 2013 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.4B | 13.5B |
| IPO Year | 2020 | 2003 |
Fundamental Metrics
Financial Performance| Metric | PCVX | SNX |
|---|---|---|
| Price | $60.12 | $200.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | $98.33 | ★ $185.50 |
| AVG Volume (30 Days) | ★ 1.1M | 775.0K |
| Earning Date | 05-06-2026 | 03-31-2026 |
| Dividend Yield | N/A | ★ 0.98% |
| EPS Growth | N/A | ★ 25.16 |
| EPS | N/A | ★ 4.04 |
| Revenue | N/A | ★ $20,053,764,000.00 |
| Revenue This Year | N/A | $8.49 |
| Revenue Next Year | N/A | $5.55 |
| P/E Ratio | ★ N/A | $48.30 |
| Revenue Growth | N/A | ★ 17.65 |
| 52 Week Low | $28.09 | $98.75 |
| 52 Week High | $65.00 | $197.58 |
Technical Indicators
Market Signals| Indicator | PCVX | SNX |
|---|---|---|
| Relative Strength Index (RSI) | 62.82 | 81.24 |
| Support Level | $42.30 | $146.57 |
| Resistance Level | $65.00 | N/A |
| Average True Range (ATR) | 2.25 | 8.11 |
| MACD | 0.62 | 4.63 |
| Stochastic Oscillator | 80.04 | 91.53 |
Price Performance
Historical ComparisonAbout PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.
About SNX TD SYNNEX Corporation
TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.